Uncategorized

Executive summary of the Public Launch of the recommendations

chance2025-03-12T15:35:27+01:00

Executive summary of the Public Launch of the recommendationschance2025-03-12T15:35:27+01:00

SISAQOL-IMI Launches Final Recommendations

chance2025-03-12T15:38:07+01:00

SISAQOL-IMI Launches Final Recommendationschance2025-03-12T15:38:07+01:00

Public Launch of SISAQOL-IMI Recommendations

mturek2025-03-12T15:38:40+01:00

Public Launch of SISAQOL-IMI Recommendationsmturek2025-03-12T15:38:40+01:00

SISAQOL-IMI receives the 2024 SPAIG Award

mturek2025-03-12T15:39:05+01:00

SISAQOL-IMI receives the 2024 SPAIG Awardmturek2025-03-12T15:39:05+01:00

Third SISAQOL-IMI Consensus Meeting

2025-03-12T15:40:14+01:00

Third SISAQOL-IMI Consensus Meeting2025-03-12T15:40:14+01:00

Second SISAQOL-IMI Consensus Meeting

2025-03-12T15:40:56+01:00

Second SISAQOL-IMI Consensus Meeting2025-03-12T15:40:56+01:00

Standardizing the design, analysis, and interpretation of patient-reported outcomes in cancer clinical trials

2025-03-12T15:41:49+01:00

Standardizing the design, analysis, and interpretation of patient-reported outcomes in cancer clinical trials2025-03-12T15:41:49+01:00

The SISAQOL-IMI Project has received funding from the Innovative Health Initiative 2 joint undertaking under grant agreement No 945052. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.